Cargando…
Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting
Developments in investigational agents and novel regimens in acute myeloid leukemia (AML) were reported in the 2022 American Society of Hematology (ASH) annual meeting. Encouraging efficacy data were presented from first-in-human studies of two investigational menin inhibitors, SNDX-5613 and KO-539,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983204/ https://www.ncbi.nlm.nih.gov/pubmed/36869366 http://dx.doi.org/10.1186/s13045-023-01411-x |